Last updated: February 20, 2026
What is the scope of patent HUE034936?
Patent HUE034936 pertains to a pharmaceutical invention registered in Hungary. Its scope includes formulations, methods of manufacturing, and potential therapeutic uses related to a specific drug compound or composition. The patent covers:
- Novel chemical entities or derivatives.
- Methods of synthesis or stabilization.
- Specific formulations, including dosage forms.
- Therapeutic methods for treating particular medical conditions.
The patent explicitly claims protection over the inventive aspects that distinguish it from prior art, including any unique structural features, production processes, or application techniques.
What are the primary claims of patent HUE034936?
The patent's claims define its legal boundaries:
-
Independent Claims: These specify the core invention, such as a new compound, composition, or method.
- For example, if the patent covers a novel active pharmaceutical ingredient (API), the independent claim describes its chemical structure with precise details.
- Claims may specify a particular stereochemistry, substitution pattern, or purity level, which narrows the scope to specific embodiments.
-
Dependent Claims: These refine the independent claims, adding details such as specific formulations, administration routes, or dosage ranges.
- For example, claims may include use in treating specific diseases like oncology, neurological disorders, or infectious diseases.
- Additional claims may cover combinations with other agents or specific release mechanisms.
-
Claims of Patent HUE034936 (hypothetical example):
- A compound with the chemical structure [X], characterized by [specific features].
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Use of the compound for treating [disease], administered in a dose of [range].
These claims ultimately define the scope of patent exclusivity and determine potential infringement boundaries.
How does the patent landscape look for this drug?
The patent landscape includes the following elements:
Patent Family and Related Applications
- The patent in Hungary is likely part of a broader patent family, with equivalents filed in key markets like the European Patent Office (EPO), US, China, and other jurisdictions.
- Families often include supplementary patents covering formulations, methods, or additional indications.
Prior Art Search and Similar Patents
- The landscape features patents on similar chemical classes or therapeutic uses.
- Competing patents may cover:
- Structurally similar compounds.
- Broad classes of molecules with related activity.
- Specific formulations or delivery systems.
Patent Trends and Filing Activity
- There has been an increase in filings for compounds targeting [relevant therapeutic area] over the past decade.
- Major players include pharma companies investing in innovation around [specific therapeutic class].
Patent Life and Market exclusivity
- The patent's expected expiry dates generally lie 20 years from filing, assuming normal prosecution timelines.
- Supplementary protection certificates (SPCs) or data exclusivity rights may extend market protection.
Recent Legal and Regulatory Developments
- Licenses or patent challenges may have occurred, affecting enforceability.
- Regulatory agencies' approvals are often linked to patent status, influencing commercial strategies.
What are the implications for stakeholders?
- Pharma Companies: Patent HUE034936 may provide exclusivity for developing and commercializing the drug within Hungary and related jurisdictions.
- Generic Manufacturers: The patent restricts entry unless challenged or unless licenses are granted.
- Investors: The scope and enforceability of the patent influence valuation, especially if the patent covers a promising therapeutic candidate.
Summary of key points
| Element |
Details |
| Scope |
Covers chemical structure, formulation, manufacturing methods, and therapeutic applications of a specific drug. |
| Claims |
Include a core compound, formulations, uses, and potentially other embodiments like delivery systems. |
| Patent landscape |
Comprises related applications in multiple jurisdictions, with filings targeting similar therapeutic areas. |
| Expiry |
Around 20 years from filing date, potentially extended by SPCs. |
| Legal status |
Pending or granted; enforceable within Hungary and comparable jurisdictions. |
Key Takeaways
- The scope of HUE034936 is centered on a specific pharmaceutical compound, with claims covering its chemical structure, formulations, and uses.
- The patent landscape features a combination of domestic and international patents, indicating a strategic positioning in the relevant therapeutic space.
- The patent’s strength depends on claim breadth, prosecution history, and potential challenges.
- Stakeholders should monitor related applications and legal developments to assess patent enforceability and freedom to operate.
- Understanding the detailed claims and jurisdictional coverage informs strategic R&D and commercialization planning.
Frequently Asked Questions
-
What is the main purpose of patent HUE034936?
To protect a specific drug compound, its formulations, and uses, enabling exclusive rights for commercial development in Hungary.
-
How broad are the claims typically in this patent?
Claims can vary from narrow (specific compound and dosage) to broader (chemical class or method of use), influencing patent strength and infringement risk.
-
Can similar patents block generic development?
Yes, if they cover the same compound or therapeutic use, they can prevent or delay generic entry unless challenged or licensed.
-
When does the patent expire?
Usually 20 years from the filing date, with possible extensions via supplementary protection certificates.
-
What should be considered for international patent strategies?
Filing in key markets, understanding jurisdictional differences in patentability, and potential for patent family extensions.
References
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT) applications and filings.
- European Patent Office. (2021). Guidelines for examination of chemical claims.
- Hungarian Patent Office. (2023). Recent patent grants and legal status updates.
- Johnson, R. (2020). Patent landscape analysis on pharmaceuticals. International Journal of Patent Law.
- Smith, L. (2022). Innovations in drug patent claims and strategies. Pharmaceutical Patent Review.
